Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS): Douglas Braunstein And James Woolery’s Hudson Executive Capital filed an amended 13D.
You can check out Hudson Executive Capital’s latest holdings and filings here.
Please follow Hudson Executive Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Hudson Executive Capital or update its stock holdings.
Follow Douglas Braunstein And James Woolery's Hudson Executive Capital
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Hudson Executive Capital | 0 | 26,861,154 | 0 | 26,861,154 | 26,861,154 | 14.2% |
| HEC Management GP | 0 | 26,861,154 | 0 | 26,861,154 | 26,861,154 | 14.2% |
| Douglas L. Braunstein | 0 | 26,861,154 | 0 | 26,861,154 | 26,861,154 | 14.2% |
Follow Douglas Braunstein And James Woolery's Hudson Executive Capital
Page 1 of 8 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE
13D/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
Corindus
Vascular Robotics, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
218730109
(CUSIP Number)
Michael D. Pinnisi
Hudson Executive Capital LP
570 Lexington Avenue, 35th Floor
New York, NY 10022
(212)
521-8495
Copies to:
Stuart Bressman
Proskauer Rose LLP
Eleven Times Square
New
York, NY 10036
(212) 969-3000
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
March 16, 2018
(Date of Event Which Requires Filing of this Statement)
If the filing person has
previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e),
13d-1(f) or 13d-1(g), check the following box. ☐
Note: Schedules filed in paper format
shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
| * | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
